Relationship of hepatitis C genotype 1 NS5A sequence mutations to early phase viral kinetics and interferon effectiveness

Journal of Infectious Diseases

Volumn 185, Issue 7, 2002, Pages 868-877

  Schiappa, Deborah A ^a   Mittal, Chetna ^a   Brown, Jennifer A ^a   Mika, Brian P ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PROTEIN KINASE;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HEPATITIS C; HUMAN; LIVER CELL; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS INHIBITION;

ADULT; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 0036534466     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/339485     Document Type: Article

References (47)

1. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
2. Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial
3. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
4. Randomized trial of interferon α-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
5. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C vires 1b
6. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
7. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa
8. Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy
9. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity
10. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b
11. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients
12. The interferon sensitivity determining region: All hepatitis C virus isolates are not the same
13. The interferon system: A bird's eye view of its biochemistry
14. Interferon-induced antiviral actions and their regulation
15. Protein kinases that phosphorylate eIF-2 and EIF-2B, and their role in eukaryotic cell translational control
16. A double-stranded RNA activated protein kinase-dependent pathway mediating stress-induced apoptosis
17. Antiapoptotic and oncogenic potentials of hepatitis virus are linked to interferon resistance by viral repression of the PKR kinase
18. Induction of apoptosis by double-stranded-RNA-dependent PKR involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-κβ
19. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation
20. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
21. Protein processing of hepatitis C virus and investigation of the effects of viral proteins on cell proliferation
22. Hepatitis C viral dynamics in vivo and the antiviral effects triggered by IFN-alpha therapy
23. Dose-dependent acute clearance of hepatitis C genotype 1 virus with integeron alfa
24. Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus
25. Dose-dependent effectiveness of consensus interferon alfacon-1 (Infergen) in blocking in-vivo HCV production
26. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources
27. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection
28. Clustal W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice
29. CLUSTAL V: Improved software for multiple sequence alignment
30. Fast and sensitive multiple sequence alignments on a microcomputer
31. Genetic organization and diversity of the hepatitis C virus
32. GOR method for predicting protein secondary structures from amino acid sequence
33. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins
34. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection
35. Evolution of hepatitis C virus quasi-species in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection
36. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy
37. Mutations in the NS5A gene predict response to interferon therapy in Japanese patients with chronic hepatitis C and cirrhosis
38. Variation in the hepatitis C virus NS5A region in relation to hypervariable region 1 heterogeneity during interferon treatment
39. The "interferon sensitivity determining region" of hepatitis C virus is a stable sequence element
40. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa
41. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients
42. The non-structural 5A protein of hepatitis C virus
43. Resistance to human immunodeficiency virus type 1 protease inhibitors
44. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society - USA panel
45. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner
46. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase